Annual Long Term Debt
$822.50 M
+$83.42 M+11.29%
31 December 2023
Summary:
BioCryst Pharmaceuticals annual long term debt is currently $822.50 million, with the most recent change of +$83.42 million (+11.29%) on 31 December 2023. During the last 3 years, it has risen by +$574.18 million (+231.22%). BCRX annual long term debt is now at all-time high.BCRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$806.25 M
-$12.71 M-1.55%
30 September 2024
Summary:
BioCryst Pharmaceuticals quarterly long term debt is currently $806.25 million, with the most recent change of -$12.71 million (-1.55%) on 30 September 2024. Over the past year, it has dropped by -$36.90 million (-4.38%). BCRX quarterly long term debt is now -4.38% below its all-time high of $843.15 million, reached on 30 September 2023.BCRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCRX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.3% | -4.4% |
| 3 y3 years | +231.2% | +488.1% |
| 5 y5 years | +2829.7% | +1526.0% |
BCRX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +231.2% | -4.4% | +488.1% |
| 5 y | 5 years | at high | +2829.7% | -4.4% | +2516.7% |
| alltime | all time | at high | >+9999.0% | -4.4% | >+9999.0% |
BioCryst Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $806.25 M(-1.6%) |
| June 2024 | - | $818.96 M(-0.6%) |
| Mar 2024 | - | $824.14 M(+0.2%) |
| Dec 2023 | $822.50 M(+11.3%) | $822.50 M(-2.4%) |
| Sept 2023 | - | $843.15 M(+2.2%) |
| June 2023 | - | $825.10 M(+9.6%) |
| Mar 2023 | - | $752.87 M(+1.9%) |
| Dec 2022 | $739.08 M(+25.0%) | $739.08 M(+2.7%) |
| Sept 2022 | - | $719.62 M(+377.5%) |
| June 2022 | - | $150.71 M(-75.3%) |
| Mar 2022 | - | $610.92 M(+3.3%) |
| Dec 2021 | $591.42 M(+138.2%) | $591.42 M(+331.4%) |
| Sept 2021 | - | $137.09 M(+4.7%) |
| June 2021 | - | $130.90 M(+3.1%) |
| Mar 2021 | - | $126.92 M(-48.9%) |
| Dec 2020 | $248.32 M(+455.6%) | $248.32 M(+705.9%) |
| Sept 2020 | - | $30.81 M(-13.3%) |
| June 2020 | - | $35.55 M(-11.7%) |
| Mar 2020 | - | $40.24 M(-10.0%) |
| Dec 2019 | $44.70 M(+59.2%) | $44.70 M(-9.9%) |
| Sept 2019 | - | $49.58 M(-7.5%) |
| June 2019 | - | $53.59 M(+8.0%) |
| Mar 2019 | - | $49.62 M(+76.7%) |
| Dec 2018 | $28.07 M(+44.0%) | $28.07 M(-9.4%) |
| Sept 2018 | - | $31.00 M(+91.6%) |
| June 2018 | - | $16.18 M(-9.3%) |
| Mar 2018 | - | $17.84 M(-8.5%) |
| Dec 2017 | $19.50 M(-23.5%) | $19.50 M(-7.8%) |
| Sept 2017 | - | $21.15 M(-6.8%) |
| June 2017 | - | $22.70 M(-6.6%) |
| Mar 2017 | - | $24.32 M(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $25.48 M(+972.9%) | $25.48 M(+0.6%) |
| Sept 2016 | - | $25.34 M(+878.8%) |
| June 2016 | - | $2.59 M(+3.3%) |
| Mar 2016 | - | $2.51 M(+5.5%) |
| Dec 2015 | $2.38 M(-92.1%) | $2.38 M(-92.1%) |
| Mar 2014 | - | $30.00 M(0.0%) |
| Dec 2013 | $30.00 M(0.0%) | $30.00 M(0.0%) |
| Sept 2013 | - | $30.00 M(0.0%) |
| June 2013 | - | $30.00 M(0.0%) |
| Mar 2013 | - | $30.00 M(0.0%) |
| Dec 2012 | $30.00 M(0.0%) | $30.00 M(0.0%) |
| Sept 2012 | - | $30.00 M(0.0%) |
| June 2012 | - | $30.00 M(0.0%) |
| Mar 2012 | - | $30.00 M(0.0%) |
| Dec 2011 | $30.00 M(>+9900.0%) | $30.00 M(0.0%) |
| Sept 2011 | - | $30.00 M(0.0%) |
| June 2011 | - | $30.00 M(0.0%) |
| Mar 2011 | - | $30.00 M(>+9900.0%) |
| Mar 2000 | - | $2700.00(-97.3%) |
| June 1997 | - | $100.00 K(0.0%) |
| Dec 1996 | $100.00 K(-66.7%) | $100.00 K(0.0%) |
| Sept 1996 | - | $100.00 K(0.0%) |
| June 1996 | - | $100.00 K(-50.0%) |
| Mar 1996 | - | $200.00 K(-33.3%) |
| Dec 1995 | $300.00 K(-50.0%) | $300.00 K(-25.0%) |
| Sept 1995 | - | $400.00 K(0.0%) |
| June 1995 | - | $400.00 K(-20.0%) |
| Mar 1995 | - | $500.00 K(-16.7%) |
| Dec 1994 | $600.00 K | $600.00 K(0.0%) |
| Sept 1994 | - | $600.00 K(-14.3%) |
| June 1994 | - | $700.00 K(-12.5%) |
| Mar 1994 | - | $800.00 K |
FAQ
- What is BioCryst Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual long term debt year-on-year change?
- What is BioCryst Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly long term debt year-on-year change?
What is BioCryst Pharmaceuticals annual long term debt?
The current annual long term debt of BCRX is $822.50 M
What is the all time high annual long term debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual long term debt is $822.50 M
What is BioCryst Pharmaceuticals annual long term debt year-on-year change?
Over the past year, BCRX annual long term debt has changed by +$83.42 M (+11.29%)
What is BioCryst Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of BCRX is $806.25 M
What is the all time high quarterly long term debt for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly long term debt is $843.15 M
What is BioCryst Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, BCRX quarterly long term debt has changed by -$36.90 M (-4.38%)